The following study describes a methodology to establish, control, and characterize an aerosolized bioburden within a test chamber and determine the settling rate of the bioburden.
Debashis Sahoo
Advertisement
Debashis Sahoo is Executive Vice-President, Regulators & Key Customers, MedInstill Development.
Articles by Debashis Sahoo
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Updates Master Protocol: What Developers Need to Know
2
Pharma Fundamentals: Hold Times in Biopharmaceuticals
3
IPEC’s Excipient Information Package: A Standardized Communication Platform for Sharing Excipient Information as an Alternative to Questionnaires
4
Merck KGaA Launches Saturnus Bio; Announces Awards
5